Zydus Wellness Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
ZYDUSWELL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Wellness reported strong standalone growth with revenue from operations rising to ₹877M in Q1 FY26 from ₹634M a year ago (~38% growth), while standalone net profit rose to ₹70M from ₹62M and EPS came in at ₹1.10 vs ₹0.97. On a consolidated basis, revenue from operations edged up modestly to ₹8,609M from ₹8,410M (~2.4% growth), but net profit declined to ₹1,279M from ₹1,477M (~13% fall), with EPS slipping to ₹20.10 from ₹23.21. The auditor (Mukesh M. Shah & Co.) issued an unqualified limited review report with no qualifications or emphasis of matter. Key context: the company completed the acquisition of Naturell (India) Pvt Ltd (NIPL) in December 2024 for ₹3,900M, and NIPL has now been put into voluntary liquidation from July 1, 2025, with its business to be absorbed back into Zydus Wellness. Deferred tax expense for the quarter includes a ₹146M reversal of MAT credit entitlement.
Standalone numbers look strong, likely boosted by the NIPL integration, but consolidated profit decline and the unusual MAT credit reversal mean underlying earnings quality is mixed. Shareholders should watch for the NIPL business consolidation benefit to show up in coming quarters, while short-term stock reaction may be cautious given the consolidated profit dip.